ProScan Imaging has acquired WorldCare Clinical (WCC) LLC, increasing its majority ownership to 100%. The acquisition expands the companies’ synergies in technology, service offerings, expertise, and accredited educational programs for clients.
“The acquisition allows us to more closely align WCC’s exceptional trial management and assessment accuracy and consistency testing methodology with ProScan’s world-wide medical image file exchange platform and its international teleradiology assets,” said Michael O’Brien, president and chief operating officer of the ProScan family of companies. “The enhanced service delivery model will allow WCC’s customers to lower their trial costs, while flexibly accessing the most appropriate independent expert assessment team.”
“Our access to large groups of sub-specialty trained, practicing radiologists and clinicians at ProScan and Harvard teaching hospitals coupled with our rapid turnaround global teleradiology and telemedicine endpoint assessment committees (EACs), all uniquely position us to take advantage of the ever changing and more rigorous clinical trial requirements,” said Dr. Richard Walovitch, president of WCC. “As the number of stakeholders involved in product life cycle management increases, WCC can provide continuity and efficiency of service, effective efficacy and safety evaluation, reporting, and continuing medical education, informing these stakeholders on the best path for their product from early clinical trial activity through commercialization.”